VF
ABBV icon

Vilas Fund’s AbbVie ABBV Stock Holding History

Vilas Fund’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$1.67M Buy
+22,000
New +$1.51M 2.24% 15

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Vilas Fund's ABBV Position: Q3 2019 in Review

Vilas Fund opened a new position in AbbVie (ABBV) in Q3 2019: 22,000 shares worth $1.67M. The stake represents 2.24% of the portfolio and ranks #15 among its holdings.

2,002 funds tracked by Wall St. Rank hold ABBV as of Q3 2019.

  • Vilas Fund held 22,000 shares of AbbVie worth $1.67M as of Q3 2019.
  • AbbVie was a new Vilas Fund position in Q3 2019.
  • AbbVie made up 2.24% of Vilas Fund's portfolio in Q3 2019, its #15 holding.
  • 2,002 funds tracked by Wall St. Rank held AbbVie as of Q3 2019.

Based on Vilas Fund's 13F filing for Q3 2019, filed 14 Nov 2019.